The phrase "ancillary tissues" is correct and usable in written English.
It can be used in contexts related to biology, medicine, or anatomy to refer to supporting or supplementary tissues that assist the primary function of an organ or system.
Example: "The study focused on the role of ancillary tissues in the healing process of the injured organ."
Alternatives: "supporting tissues" or "auxiliary tissues".
GOLPH2 has been described as an excellent ancillary tissue biomarker for the diagnosis of prostate cancer [ 20- 22].
Anatomic Pathology specialty training including: dermatopathology, forensic pathology, AP ancillary studies/molecular, tissue hematopathology, bone marrow hematopathology, neuropathology and additional selective block(s).
The high rate of GOLPH2 protein overexpression, which is also seen in AMACR-negative prostate cancer cases, suggests its use as an additional ancillary positive tissue marker of prostate cancer.
Monoclonal antibodies will be particularly useful reagents for analysing the tissue distribution of lymphoid subpopulations and ancillary cells in tissue biopsy specimens.
Lymph nodes were assessed for their size, shape, internal architecture, echogenicity, nodal border, posterior enhancement, and ancillary features (adjacent soft tissues oedema, and matting).
At the tip of the sperm head is the acrosome, a specialized sack of enzymes that help the sperm penetrate through what Joseph S. Tash, a male fertility expert at the University of Kansas Medical Center, calls the "forest" of ancillary cells and connective tissue that surrounds the ripe, ready egg.
These data clearly suggest GOLPH2 as an additional ancillary positive marker for tissue-based diagnosis of prostate cancer.
The enzymatic products of these genes are not usually involved directly in lethality but play ancillary roles in causing tissue inflammation and destruction (further details are discussed below).
Furthermore, because diagnostic biopsy samples are relatively small, the amount of residual tissue for additional ancillary testing may be inadequate.
To help distinguish melanoma from its imitators, a variety of tissue biomarkers and ancillary techniques (eg, immunohistochemical [IHC] analysis or fluorescence in situ hybridization) are currently available.
